[Usefulness of phase 3 and 4 immunization with MR vaccine].
Ozaki T, Nishimura N, Gotoh K, Horiba K, Hattori F, Takeuchi S, Funahashi K, Yoshii H, Okuno Y.
Ozaki T, et al. Among authors: horiba k.
Kansenshogaku Zasshi. 2014 Sep;88(5):711-2. doi: 10.11150/kansenshogakuzasshi.88.711.
Kansenshogaku Zasshi. 2014.
PMID: 25672144
Clinical Trial.
Japanese.
No abstract available.